Skip to main content

Table 1 Patient demographics

From: Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02

Characteristics

Number of patients (%), n=14

Gender

 

Male

13 (93)

female

1 (7)

Age (years)

 

Median

58

Range

51-78

Comorbidities

 

Chronic cardiac disease

7 (50)

Pulmonary disease

4 (28)

UICC stage

 

III

6 (43)

IV

8 (56)

Primary site

 

Oropharynx

7 (50)

Hypopharynx

3 (20)

Larynx

2 (15)

Oral cavity

2 (15)